Near-Equivalent Q-learning Policies for Dynamic Treatment Regimes

Researchers Sophia Yazzourh and Erica E.M. Moodie have published a significant advancement in precision medicine AI with their paper "Near-Equivalent Q-learning Policies for Dynamic Treatment Regimes." The work addresses a critical limitation in current clinical AI systems: most dynamic treatment regime approaches produce a single optimal treatment recommendation at each stage, creating rigid decision sequences. In reality, multiple treatment options often yield similar expected outcomes, and focusing on a single "best" policy can obscure meaningful alternatives that might better suit individual patient circumstances.

The researchers extend the Q-learning framework by introducing a worst-value tolerance criterion controlled by a hyperparameter ε, which specifies the maximum acceptable deviation from optimal expected value. This transforms Q-learning from a vector-valued representation to a matrix-valued one, allowing multiple admissible value functions to coexist during backward recursion. The approach yields families of near-equivalent treatment strategies and explicitly identifies regions of treatment indifference where several decisions achieve comparable outcomes.

In practical terms, this means AI systems can now present clinicians with multiple viable treatment pathways rather than a single prescribed sequence. The framework was tested in two settings: a single-stage problem highlighting indifference regions around decision boundaries, and a multi-stage decision process based on a simulated oncology model describing tumor size and treatment toxicity dynamics. This represents a paradigm shift from deterministic to probabilistic decision support in clinical AI.